The Tema Cardiovascular and Metabolic ETF (Ticker: HRTS) is a specialized exchange-traded fund designed to provide investors with targeted exposure to the innovative and rapidly evolving sectors within the health care industry. Focusing on the Pharma, Biotech & Life Sciences niche, this ETF is dedicated to companies at the forefront of cardiovascular and metabolic health advancements. It seeks to capture the growth potential of firms pioneering treatments, technologies, and research aimed at combating prevalent health issues such as heart disease, diabetes, and other metabolic disorders. By investing in HRTS, investors gain access to a curated portfolio of leading-edge companies that are shaping the future of health care, driving significant improvements in patient outcomes, and potentially transforming the landscape of medical science. This sector-focused ETF is an ideal choice for those looking to capitalize on the intersection of healthcare innovation and market opportunity in the cardiovascular and metabolic domains.

Tema Cardiovascular and Metabolic ETF (HRTS) Fund Flow Chart

Tema Cardiovascular and Metabolic ETF (HRTS) 1 year Net Flows: $37M

HRTS ETF News

PremiumThe Fly

UnitedHealth selloff after DOJ fraud probe ‘perhaps overly harsh,’ says Leerink

5h ago

UNH

PremiumThe Fly

UnitedHealth: WSJ reporting ‘misinformation’ on MA program

6h ago

UNH

PremiumThe Fly

UnitedHealth: Suggestions that practices are fraudulent ‘outrageous and false’

6h ago

UNH

PremiumBlurbs

UnitedHealth (UNH) Receives a Buy from Bank of America Securities

6h ago

UNH

See More HRTS News

HRTS ETF FAQ

What was HRTS’s price range in the past 12 months?

HRTS lowest ETF price was $28.56 and its highest was $36.03 in the past 12 months.

What is the AUM of HRTS?

As of Feb 20, 2025 The AUM of HRTS is 70.33M.

Is HRTS overvalued?

According to Wall Street analysts HRTS’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does HRTS pay dividends?

HRTS pays a Notavailable dividend of $0.469 which represents an annual dividend yield of 1.53%. See more information on HRTS dividends here

How many shares outstanding does HRTS have?

HRTS has 2,300,000 shares outstanding.

Which hedge fund is a major shareholder of HRTS?

Currently, no hedge funds are holding shares in HRTS

HRTS ETF Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
$39.71 (― Downside)

Blogger Sentiment

Bullish

Crowd Wisdom

Very Negative

Technicals

Learn more about TipRanks Smart Score

For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.

Go to Top Smart score ETFs >